chrisvoncsefalvay/vaers-outcomes huggingface dataset:
T101, aches, congestion, sore arms, fatigue-small erythematous area on both arms @ sites of inj;sx worsened T103 rt inj site redness & induration;
14 years patient received BNT162b2  vaccine; Second Dose: pain under arm around arm pit area; left arm, same one she received the shot in; Second Dose: Left Arm Injection Site Pain; This is a spontaneous report received from a Pfizer sponsored program. A contactable consumer (patient's mother) reported that a 14-years-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 07Jun2021 (Batch/Lot Number: EW0196; Expiration Date: Sep2021) as SINGLE DOSE for COVID-19 immunisation. The patient's medical history was reported as none. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EW0187, Expiration date: Aug2021), via an unspecified route of administration in the left arm on 17May2021 for COVID-19 immunization and expereinced left arm injection site pain. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. No investigation assessment was provided. Caller stated the patient had a sore left arm at the injection site with her first injection and it was worse than the injection site pain this time. Caller stated it lasted about 2 days after her first injection, so 17May2021, 18May2021, and 19May2021. Caller stated this time with the second dose, the injection site pain was less than the first time, but now she has pain under her arm at the arm pit area. Caller stated after the second dose the injection site pain was just that day, so just one day, it wasnot bad. Pain under arm around arm pit area; left arm, same one she received the shot in. Therapeutic measures were taken as a result of second dose: pain under arm around arm pit area; left arm, same one she received the shot in and second dose and left arm injection site pain with Advil. The outcome of the event second dose: left arm injection site pain was recovered on 07Jun2021; event second dose: pain under arm around arm pit area; left arm, same one she received the shot in was not recovered and unknown for other event.   Lot/batch no. detail are available. Additional information has been requested.
Approx 12 hours later pain at site increased to level 10 and radiated to my neck. Temp elevated to 104 muscle spasms from legs to neck began every 10 mins lasted about 4-6 hours. Temp 102 next day very lethargic for 3 days. Temp 99.5. 01/02/07-records received and reviewed puncture wound to finger on 10/16/06, tetanus shot with pertussis on 10/18/06. Developed fever to 102, muscle aches without real arthralgias, headache,  seen on 10/15/06 impression acute serum sickness type reaction to tetanus shot, question whether it was the pertussis component. Developed cramping in legs and buttocks, RX with Prednisone. Visit 11/15/06 massive headache, visual disturbance.  will see in 2 weeks.
No additional information provided; an expired dose of ROTATEQ was administered to the patient; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapies were not reported.  On 22-MAR-2022, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 2 mL, lot #1707460, expiration date: 14-MAR-2022 (strength, and route of administration were not provided) for prophylaxis (expired product administered). The administered vaccine had not been involved in any temperature excursions. No additional information provided.  This is one of three reports received from the same reporter.; Sender's Comments:  US-009507513-2203USA008707: US-009507513-2203USA008826:
Within a couple minutes of receiving vaccine I became very sweaty, dizzy, increased heart rate. Medic had me lay down with feet elevated, cold compress. I felt ok enough to drive home after 30 mins. The next day I woke up very sick, like I had the flu. Sweating, chills, extremely achy, upset stomach, diarrhea, pain at injection site and numbness:tingling in left arm all the way down to pinky finger. Next day I woke up with a bright red rash all around base of neck. Next day woke up a lot better.
pt recv vax 18FEB99 345PM & no c/o until 5PM @ which time c/o itching all over & feeling jittery all over;Solumedrol IVP, DPH, Pepcid, IVP administered;
Pain in left upper arm (injection in (L) upper arm) from 10/31/12 -> 11/3/12. Dull headache from 10/31/12 -> 11/4/12.
Fever 102-103 chills sweats right arm pain, redness down to mid arm, swelling -lasted 5 days. Tx with ice, ADVIL.
Pityriasis rosea; Hives; fever probably close to 101; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives), PITYRIASIS ROSEA (Pityriasis rosea) and PYREXIA (fever probably close to 101) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023C21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-May-2021, the patient experienced PYREXIA (fever probably close to 101). On 17-May-2021, the patient experienced URTICARIA (Hives). On an unknown date, the patient experienced PITYRIASIS ROSEA (Pityriasis rosea). At the time of the report, URTICARIA (Hives), PITYRIASIS ROSEA (Pityriasis rosea) and PYREXIA (fever probably close to 101) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medications were not reported.   It was reported that patient received a shot from the dermatologist, which subsided the hives a bit. He had a second dose of that injection three weeks later. Today 12Jul2021 his hives are minimum compared to what it was, but it's starting to grow again. He is going in for his third appointment on Thursday 15Jul2021. Consent given for safety to contact the patient and his dermatologist. He states he will not be taking the booster shot if he doesn't have to   This case was linked to MOD-2021-254038 (Patient Link).
This spontaneous report has been received from a nurse, concerning  an unspecified number of patients of unknown age and gender. The patients' medical history and concurrent conditions were not provided. On unknown dates,  the reporter stated that he/she was unsure if patients received improperly stored doses of VARIVAX subcutaneous, lot # M042496 and expiration date 11-MAY-2018 (dose was not provided) for prophylaxis and which were reconstituted with properly stored sterile diluent. The vaccine was stored at a temperature of 0° Centigrade, time frame of 10 hours and previous temperature excursion of (0° centigrade for 13 hours 30 minutes).  Digital Data logger was involved. report. There was no product quality complaint involved. Additional information has been requested.
vasovagal syncope episode, pt. responsive after 60 seconds, answering questions appropriately, small gash noted on hear from the fall, taken to triage POD B via w/c after doctor cleared pt. pt. remains A&OX3, EMT on site, pt. taken via stretcher to ambulance.
my left calf was hurting within a week of the vaccine, went to ER in Jan 2021 and was told I had a blood clot in my left calf  and was put on blood thinners for 12 weeks, went off blood thinner and a few months later back in ER with serval blood clots including in heart and lungs put back on Heparin again, after leaving the Hospital again for blood clots , I went to a specialist and he did genetic testing for any clotting disorders and found nothing that would cause blood clots,   was told I will never be off blood thinners for the rest of my life. there were no medical issues until this vaccine .   Eliquis 5 mg tablet X 2 times a day .
Swelling and redness at injection site. Pt complains of dizziness and pain radiating from site to elbow. Treated by MD with Benadryl and Tylenol. Also c/o swelling to axillary lymph nodes.
23MAY96 recv vax, then in evening was seen-floppy baby;sent to neuro @ hosp;neuro dx benign vertigo ? toxin ? acute cerebral ataxia
get sick every time; Initial information regarding this unsolicited valid non-serious social media case received from a consumer (patient) on 05-Dec-2020.  This case involves a patient with unknown demographics who get sick every time (Illness) when received vaccine INFLUENZA VACCINE.  Relevant medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient get sick every time (Illness), following the administration of INFLUENZA VACCINE (flu shot). The patient did not know it was flu shot or not.  Relevant laboratory test not reported.  It was not reported if the patient received a corrective medication.  At the time of reporting, the outcome was unknown for the reported event.  There will be no information available on batch number for this case.
This case was reported by a consumer via call center representative and described the occurrence of feeling bad in a adult male patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX (received 1st dose of SHINGRIX on 30th May 2018.). On 8th January 2019, the patient received the 2nd dose of SHINGRIX. On 8th January 2019, unknown after receiving SHINGRIX, the patient experienced product supply issue. On an unknown date, the outcome of the product supply issue was unknown. Additional details were provided as follows: The age at vaccination was not reported. The patient reported that he had his first dose and his second dose was late because the patient unable to get the injection due to supply issue. The patient refused to provide his age or date of birth. Consented to follow up was provided. The patient was request reimbursement. Follow up information received from consumer on 28th January 2019: On 8th January 2019, the patient received the 2nd dose of SHINGRIX which was later the recommended schedule, which led to lengthening of the vaccination schedule. Less than a month after receiving SHINGRIX the patient ended up in bed because it made him feel so lousy. The patient was unwilling to provide any further details as he wanted to get off the phone. The patient stated that he tried to get the 2nd SHINGRIX shot within the 6 month window by calling many pharmacist, and he was finally able to get the second shot in 2019 about 8 months after the first shot. This case has been linked to the US2019GSK021331, reported for the dose 1 of the same patient.
4x4 inch knot on arm, blotchy redness and arm was firm; blotchy redness; arm was firm; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot Number: EN6198),  via an unspecified route of administration, administered in left arm on 01Mar2021 (at the age of 64-years-old) as dose 2, single for covid-19 immunization.  Medical history included allergies eggs and shellfish. The patient's concomitant medications were not reported. Patient historical vaccine includes BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot Number: EL8982),  via an unspecified route of administration, administered in left arm on 08Feb2021 10:30 (at the age of 64-years-old) as dose 1, single for covid-19 immunization. Prior to vaccination, the patient was not pregnant, not diagnosed with COVID-19, did not receive any other vaccines within 4 weeks and no other medications within 2 weeks. Since the vaccination, has the patient has not been tested for COVID-19. The patient had a reaction of 4x4 inch knot on arm, blotchy redness and arm was firm on 03Mar2021. No treatment was taken for the event. The outcome of the event was recovered.  No follow-up attempts are possible. No further information is expected.
SORE, ITCHY BUMP WHEN TOUCH, LARGER THAN SILVER DOLLAR SIZE, WARM
p/2nd vax, no acute diarrhea, 8/7/99 bout of diarrhea which became grossly bloody; hosp; definitive dx not made, md suspected some type of inflammatory bowel disease; did not recv 3rd dose vax;
5/2/2020 2:30 pm dizziness, nausea lasted 8 hours. Went away.  Headache remained  5/2/2020 asthma symptoms flare up. Utilized nebulizer 5 times.  Headache remained  5/3/2020 utilized nebulizer 5 times . Headache remained  5/4/2020 utilized nebulizer 5 times. requested meds: received prednisone. 20 mg 2xs daily for 5 days.  Headache remained  5/5/2020  began treatment of prednisone. Utilized nebulizer 4 times. No headache  5/6/2020 utilized nebulizer 4 times  headache returns  5/7/2020 utilized nebulizer 3 times  headache remained  5/8/202 utilized nebulizer 1 time no headache  5/9/2020 discontinued use of nebulizer headache remains  5/10/2020 headache pain near brain stem occipital lobe region  5/11/2020  headache in the morning occipital lobe region.  Pain at the top of head corpus callosum  region.  Right down the middle. Awake at 3:41am w the pain.
loss of feeling in left hand, tip of fingers, shooting pain in thumb (comes and goes). immediately as vaccine was given area where vaccine was given swell up like a hard marble was under skin. about 3 mins after vaccine left hand got cold and all feeling was loss. Arm burned for about 12/16 hrs. feeling has not yet come back in hand
Patient is a 54-year-old male who is seen in consultation for Dr. evaluation of bilateral arm injection sites. She reports he had influenza vaccination injection in his proximal left upper extremity and hepatitis A and pneumonia vaccination injections in his proximal right upper extremity on 10/3/18. States he first noticed changes at the injection sites about 1 week following injections. States the areas is "festered up". States that 2 spots appeared on his proximal right upper extremity. States that 1 area drained on its own, and had the other lanced and packed at his PCP office about 2 months ago. Reports purulent drainage. Denies fever, chills, sweats. Patient states about 1 week ago he noticed one of the lesions filling up with clear fluid again. Reports only soreness of his proximal left upper extremity, which she states has improved over time. I&D, WTD BID, cultures obtained.
This spontaneous report was received from a health care professional refers to a patient of unknown age and gender. On 07-MAY-2015 the patient was vaccinated with improperly stored PROQUAD (Merck) (lot # K008868; expiry: 19-DEC-2015) (dose, route and frequency unspecified). No concomitant medications were reported. No adverse effects reported. There was no product quality complaint involved. The outcome of incorrect product storage was unknown. No further information provided. This is one of several reports received from the same source. Additional information has been requested.
patient received a possible dose of IPOL after the IPOL was involved in a temperature excursion that made the product not suitable for use with no reported adverse event; Initial information received on 08-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves an unknown age female patient who received a possible dose of IPV (VERO) [IPOL] after the Ipol was involved in a temperature excursion that made the product not suitable for use with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 07-Sep-2022, the patient received a  dose of suspect IPV (VERO)   vaccines exposed to a temperature range of 35.6 degrees F (Fahrenheit) to 50.2 degrees F for 27-minutes due to the clinic's air condition not working and stocking a new shipment of vaccines into the refrigerator. Vaccines Involved were Acthib, Ipol, Menquadfi, PentaceL, and Fluzone 0.5 ml. 07-Sep-2022; that the excursion occurred between 12:42 pm to 01:12 pm, on 07-Sep-2022; that at 01:12 pm the reading came in at 50.2 degrees F; that the excursion was not noted until the next day, that the alarms did not sound at the time of the excursion.  One-dose of IPOL was administered from the open bottle of IPOL (lot V1A024M exp: 17-Feb-2024) via intramuscular route in the left thigh as Immunization post excursion (poor quality product administered).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient's mother described development of "a baseball-sized hive" at injection site that persisted for two days post injection. She also reported giving Benadryl and patient was tired, nauseated, with increased nasal congestion during that time. I have reported this to Dr's office.
Several minutes after administering vaccine Pediarix(RT) and HIB(LT)  the child developed red blotchy spots to both lower extremities.
Following the first shot of the Pfizer COVID-19 vaccine, I began to experience painful joint pain throughout my entire body. I asked my doctor about the joint pain and was advised that the vaccine sometimes will cause the body to go a little haywire after getting the vaccine but will likely go away shortly. I received the second dose while still experiencing extreme joint pain. It has been approximately three months now and I am still experiencing extreme joint pain. I was healthy before and had confirmed COVID-19 in November of 2020. I recovered from Covid-19 with no residual issues amd now have an advanced stage of Rheumatoid Arthritis following the two doses of COVID-19 Pfizer vaccines.
sore Right arm, states worse than the flu shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore Right arm, states worse than the flu shot) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Flu shot. Concomitant products included PROPRANOLOL HYDROCHLORIDE (INDERAL) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore Right arm, states worse than the flu shot). On 15-Mar-2021, VACCINATION SITE PAIN (sore Right arm, states worse than the flu shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Patient contacted office about having cerva, and stated she believed that the shot her to have a torn rotator cuff when she got the shot.  We are just reporting this because it was just recently reported to us.
Patient with 3 COVID vaccines who admitted with COVID detected test for GI issues. Not hypoxic during hospital admission. Did not receive any COVID treatments.
Information has been received from a woman in a physician's office concerning a 17-week-old Hispanic male with no medical history who on 15-SEP-2006, at 14:30, was vaccinated PO with the first dose of rotavirus G1 G2 G3 G4 P1 reassortment vaccine live (human-bovine). There was no illness at the time of vaccination. No laboratory/diagnostic tests were performed as medical attention was not sought. No adverse events were reported as the patient did well. Additional information has been requested.
Hib shot given left thigh on 5/16/05, resulted in irritability and left leg swelling. Hib shot #2 given 7/13/05, also resulted in irritability and left leg swelling.
17 year old mistakenly received the first dose of the vaccine; A spontaneous report was received from a nurse concerning a 17 year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273)  The patient's medical history was not provided. No relevant concomitant medications were reported.    On 25 Jan 2021, the first dose of vaccine was administered to 17 year old female  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event was recovered.; Reporter's Comments: This report refers to a case of inappropriate age at vaccine administration for mRNA-1273 with no associated AEs.
11/12/2015 Received the flu vaccination in my right shoulder and had immediate and persistent pain. Approximately 2-3 weeks later I called my doctor to advise the pain still persisted. I was told to apply hot/cold compresses and call back if it did not resolve. I called again in early January to notify my doctor I was still having severe shoulder pain where at times I couldn't lift my arm due to pain. 3/1/2016 I saw Dr. for a sore throat and to follow up on the shoulder pain. She offered to send me to get an MRI. 3/23/2016 I had an MRI. I was notified of the results of my MRI showed edema in my shoulder. At this time I still had persistent shoulder pain. The doctor recommended physical therapy and/or to see an orthopedist. 4/21/2016 I saw PA-C for an orthopedic appointment and he noted my shoulder pain and prescribed an anti-inflammatory.
A red curved line showed up on forearm and there was a raised red area about 3-4 inches long and 2-3 inches wide. Prescribed "8-1" course prednisone and BENADRYL.
Suspected Vaccination failure/ I think I did, too / never get another shingles shot. Suffered too long after it / Never a shingles shot for me again; I think I did, too / never get another shingles shot. Suffered too long after it; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient stated that he/she suffered from shingles for long time after vaccination with shingles shot. The patient stated he/she would never get another shingles shot. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset and laboratory confirmation for shingles were not provided. This case was linked with case US2021AMR156120, reported by same reporter for different patient.
Grandparents brought child in for vaccinations with permission slip from mother to receive required shots for school. The next day an aunt of child called to say 1 week prior child had received same shots - she had taken child to doctor 1 week ago.